论文信息 - STUDY ON AN INACTIVATION EVALUATION METHOD OF CLEANING PROCESSES FOR BIOPHARMACEUTICALS - 字舞流文

STUDY ON AN INACTIVATION EVALUATION METHOD OF CLEANING PROCESSES FOR BIOPHARMACEUTICALS

Stephan O. Krause | H. Levine | H. Meyer | U. Gottschalk | S. Chrai | J. Martin | Rajesh Gupta | E. Langer | S. Kuwahara | Han-Yang Liu | F. Greer | D. Kraichely | E. G. Calamai | Hanns-Christian Mahler | L. Goren | R. Budihandojo

[1] Sarfaraz K Niazi. Viral Safety Evaluation of Biotechnology Products Derived from Cell Lines of Human or Animal Origin , 2016, Handbook of Pharmaceutical Manufacturing Formulations, Third Edition.

[2] M. Naeem. Risk based manufacture of pharmaceutical products , 2018 .

[3] QUESTIONS AND ANSWERS ON IMPLEMENTATION OF RISK-BASED PREVENTION OF CROSS- CONTAMINATION IN PRODUCTION AND ‘GUIDELINE ON SETTING HEALTH-BASED EXPOSURE LIMITS FOR USE IN RISK IDENTIFICATION IN THE MANUFACTURE OF DIFFERENT MEDICINAL PRODUCTS IN SHARED FACILITIES’ , 2013 .

[4] Guideline on quality, non-clinical and clinical aspects of medicinal products containing genetically modified cells , 2012 .

[5] Revised. VIRUS VALIDATION STUDIES : THE DESIGN , CONTRIBUTION AND INTERPRETATION OF STUDIES VALIDATING THE INACTIVATION AND REMOVAL OF VIRUSES , 1996 .